V023-1201 Screening compound: 3-{4-[(2,4-dimethoxyphenyl)methyl]-2-methyl-3-oxo-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}-1-phenylurea

V023-1201 Screening compound: 3-{4-[(2,4-dimethoxyphenyl)methyl]-2-methyl-3-oxo-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}-1-phenylurea
V023-1201 Screening compound: 3-{4-[(2,4-dimethoxyphenyl)methyl]-2-methyl-3-oxo-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}-1-phenylurea alternative view

Chemical Structure Depiction of ChemDiv screening compound V023-1201
3-{4-[(2,4-dimethoxyphenyl)methyl]-2-methyl-3-oxo-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}-1-phenylurea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V023-1201

Molecular Formula

C26H27N3O5 (C26 H27 N3 O5)

Compound Name

3-{4-[(2,4-dimethoxyphenyl)methyl]-2-methyl-3-oxo-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}-1-phenylurea

IUPAC name

3-{4-[(24-dimethoxyphenyl)methyl]-2-methyl-3-oxo-2345-tetrahydro-14-benzoxazepin-7-yl}-1-phenylurea

SMILES

CC(C(N(Cc(ccc(OC)c1)c1OC)C1)=O)Oc(cc2)c1cc2NC(Nc1ccccc1)=O

InChI

InChI=1S/C26H27N3O5/c1-17-25(30)29(15-18-9-11-22(32-2)14-24(18)33-3)16-19-13-21(10-12-23(19)34-17)28-26(31)27-20-7-5-4-6-8-20/h4-14,17H,15-16H2,1-3H3,(H2,27,28,31)/t17-/m0/s1

InChI Key

FKAWBWCQLPICEL-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD19854673

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

461.52

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.578

Distribution Coefficient, logD

4.578

Water Solubility, LogSw

-4.49

Polar Surface Area

72.058

Acid Dissociation Constant (pKa)

13.22

Base Dissociation Constant (pKb)

0.45

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

23.08

V023-1201 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V023-1201 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V023-1201?
Check Price and Availability of V023-1201, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V023-1201 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V023-1201
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V023-1201
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V023-1201 available by request